Zdrowie i gospodarka · 15/07/2024
FDA Launches Interactive Site Tours Program for Cellular and Gene Therapies Regulatory Review
The FDA's CBER is launching an interactive site tours program to enhance review efficiency and quality for regulatory project managers and reviewers, allowing them to tour biotechnology manufacturing facilities and exchange experiences with industry counterparts.